tradingkey.logo

Thermo Fisher Scientific Inc

TMO

470.030USD

-19.030-3.89%
收盤 04/03, 16:00美東報價延遲15分鐘
178.98B總市值
28.25本益比TTM

Thermo Fisher Scientific Inc

470.030

-19.030-3.89%
關於 Thermo Fisher Scientific Inc 公司
Thermo Fisher Scientific Inc. 致力於通過診斷和開發與製造改變生命的療法來幫助生命科學研究、提高實驗室生產力和改善患者健康。生命科學解決方案部門提供用於生物和醫學研究、新藥和疫苗的發現和生產以及感染和疾病診斷的試劑、儀器和消耗品組合。它還提供蛋白質組學解決方案。分析儀器部門提供用於實驗室和現場各種應用的儀器和支持消耗品、軟件和服務。專業診斷部門提供一系列診斷測試套件、試劑、培養基、儀器和相關產品,爲醫療保健、臨牀、製藥、工業和其他領域的客戶提供服務。實驗室產品和生物製藥服務部門提供實驗室所需的幾乎所有東西。
公司簡介
公司代碼TMO
公司名稱Thermo Fisher Scientific Inc
上市日期Aug 27, 1980
成立日期1960
CEOMr. Marc N. Casper
員工數量125000
證券類型Ordinary Share
年結日Aug 27
公司地址168 Third Avenue
城市WALTHAM
上市交易所NYSE Consolidated
國家United States of America
郵編02451
電話17816221000
網址https://www.thermofisher.com/
公司代碼TMO
上市日期Aug 27, 1980
成立日期1960
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
172.49K
--
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
72.41K
+0.47%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
30.37K
+26.31%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
17.12K
+74.12%
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
17.03K
+90.54%
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
13.86K
-0.12%
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resource Officer, Senior Vice President
Chief Human Resource Officer, Senior Vice President
13.80K
+28.80%
Mr. Michael A. Boxer
Mr. Michael A. Boxer
Senior Vice President, General Counsel
Senior Vice President, General Counsel
8.87K
-29.85%
Dr. Tyler Jacks
Dr. Tyler Jacks
Director
Director
8.01K
+4.42%
Ms. Ruby R. Chandy
Ms. Ruby R. Chandy
Independent Director
Independent Director
2.01K
+20.32%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
172.49K
--
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
72.41K
+0.47%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
30.37K
+26.31%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
17.12K
+74.12%
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
17.03K
+90.54%
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
13.86K
-0.12%
收入明細
單位: USD更新時間: 4月2日 週三
單位: USD更新時間: 4月2日 週三
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Service
17.84B
41.62%
Consumables
17.59B
41.02%
Instruments
7.45B
17.37%
地區USD
名稱
營收
佔比
United States
21.75B
50.74%
Europe
10.86B
25.32%
Asia Pacific
7.96B
18.55%
Other Regions
1.56B
3.64%
Northern America excluded united states
749.00M
1.75%
業務
地區
業務USD
名稱
營收
佔比
Service
17.84B
41.62%
Consumables
17.59B
41.02%
Instruments
7.45B
17.37%
股東統計
更新時間: 2月21日 週五
更新時間: 2月21日 週五
持股股東
股東類型
持股股東
股東統計
佔比
The Vanguard Group, Inc.
8.77%
BlackRock Institutional Trust Company, N.A.
4.56%
State Street Global Advisors (US)
4.36%
T. Rowe Price Associates, Inc.
2.74%
Capital World Investors
2.50%
Other
77.07%
持股股東
股東統計
佔比
The Vanguard Group, Inc.
8.77%
BlackRock Institutional Trust Company, N.A.
4.56%
State Street Global Advisors (US)
4.36%
T. Rowe Price Associates, Inc.
2.74%
Capital World Investors
2.50%
Other
77.07%
股東類型
股東統計
佔比
Investment Advisor
42.48%
Investment Advisor/Hedge Fund
36.91%
Bank and Trust
2.87%
Research Firm
2.84%
Pension Fund
2.56%
Hedge Fund
2.24%
Sovereign Wealth Fund
1.99%
Foundation
0.28%
Family Office
0.21%
Other
7.61%
機構持股
更新時間: 2月20日 週四
更新時間: 2月20日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
4272
350.09M
92.79%
-3.93M
2024Q4
4330
349.72M
92.67%
-4.90M
2024Q3
4195
348.49M
91.10%
-6.75M
2024Q2
4169
349.06M
91.37%
-3.26M
2024Q1
4150
346.74M
90.80%
-11.10M
2023Q4
4145
353.49M
91.48%
-3.65M
2023Q3
4035
353.30M
91.43%
-5.83M
2023Q2
4030
357.37M
92.63%
+1.15M
2023Q1
3992
353.61M
91.65%
-5.21M
2022Q4
3961
356.99M
91.02%
-2.42M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
33.08M
8.77%
+201.59K
+0.61%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
17.20M
4.56%
+65.72K
+0.38%
Dec 31, 2024
State Street Global Advisors (US)
16.45M
4.36%
+129.07K
+0.79%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.33M
2.74%
-64.57K
-0.62%
Dec 31, 2024
Capital World Investors
9.43M
2.5%
+104.34K
+1.12%
Dec 31, 2024
Capital Research Global Investors
7.92M
2.1%
-266.96K
-3.26%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.86M
2.08%
+197.44K
+2.58%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
6.05M
1.6%
+483.36K
+8.68%
Dec 31, 2024
Fidelity Management & Research Company LLC
5.69M
1.51%
-1.59M
-21.86%
Dec 31, 2024
JP Morgan Asset Management
5.66M
1.5%
+1.37M
+31.89%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月2日 週三
更新時間: 4月2日 週三
機構名稱
佔比
Amplify Weight Loss Drug & Treatment ETF
5.26%
Monarch Blue Chips Core ETF
4.2%
JPMorgan Healthcare Leaders ETF
3.94%
AdvisorShares Focused Equity ETF
3.85%
Honeytree US Equity ETF
3.83%
Invesco Nasdaq Free Cash Flow Achievers ETF
3.75%
Indexperts Quality Earnings Focused ETF
3.74%
Proshares Ultra Health Care
3.73%
Health Care Select Sector SPDR Fund
3.72%
iShares U.S. Healthcare ETF
3.61%
查看更多
Amplify Weight Loss Drug & Treatment ETF
佔比5.26%
Monarch Blue Chips Core ETF
佔比4.2%
JPMorgan Healthcare Leaders ETF
佔比3.94%
AdvisorShares Focused Equity ETF
佔比3.85%
Honeytree US Equity ETF
佔比3.83%
Invesco Nasdaq Free Cash Flow Achievers ETF
佔比3.75%
Indexperts Quality Earnings Focused ETF
佔比3.74%
Proshares Ultra Health Care
佔比3.73%
Health Care Select Sector SPDR Fund
佔比3.72%
iShares U.S. Healthcare ETF
佔比3.61%
分紅派息
近5年累計派現 2.29B 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Feb 19, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 15, 2025
Mar 14, 2025
Nov 07, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024
Dec 13, 2024
Jan 15, 2025
Dec 13, 2024
Jul 11, 2024
TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024
Sep 13, 2024
Oct 15, 2024
Sep 13, 2024
May 22, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 15, 2024
Jun 14, 2024
Feb 21, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 15, 2024
Mar 14, 2024
Nov 09, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 16, 2024
Dec 14, 2023
Jul 13, 2023
TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 13, 2023
Sep 14, 2023
May 24, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 14, 2023
Jun 14, 2023
Feb 22, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Apr 14, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 14, 2023
Mar 14, 2023
Nov 10, 2022
TMO.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 16, 2023 going ex on Dec 14, 2022
Dec 15, 2022
Jan 16, 2023
Dec 14, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
tradingkey.logo
tradingkey.logo
日內數據由路孚特(Refinitiv)提供,並受使用條款約束。歷史及當前收盤數據均由路孚特提供。所有報價均以當地交易所時間為準。美股報價的即時最後成交數據僅反映透過納斯達克報告的交易。日內數據延遲至少15分鐘或遵循交易所要求。
* 參考、分析和交易策略由提供商Trading Central提供,觀點基於分析師的獨立評估和判斷,未考慮投資者的投資目標和財務狀況。
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有